Table: begin end state 1 34 cytoplasmic 35 52 transmembrane 53 73 non-cytoplasmic 74 92 transmembrane 93 102 cytoplasmic 103 130 transmembrane 131 186 non-cytoplasmic 187 208 transmembrane 209 250 cytoplasmic 251 270 transmembrane 271 289 non-cytoplasmic 290 313 transmembrane 314 324 cytoplasmic 325 343 transmembrane 344 348 non-cytoplasmic 349 372 transmembrane 373 383 cytoplasmic 384 407 transmembrane 408 413 non-cytoplasmic 414 435 transmembrane 436 445 cytoplasmic
Input: >Pf6N2E2_5056 FitnessBrowser__pseudo6_N2E2:Pf6N2E2_5056 MIPSQSSRLATGLSASTGGVGDKIRGAMTVGKTRWGMLALVFFATTLNYIDRAALGVMQP ILAKEMSWTAMDYANINFWFQVGYAVGFVLQGRLIDRIGVKRVFFCAVLLWSLATGAHGL ATSAVGFMVCRFILGLTEAANYPACVKTTRLWFPAGERAVATGIFNAGTNVGAMFTPMLL PLVLHVWGWQAAFLCMAALGGIWLVFWGLKYFNPEDHPTVKQSELDYIQAQDEPDQVRVP FSRILRMRGTWAFALAYSITAPVFWFYLYWLPPFLNQQYNLGINVTQMGIPLIIIYLTAD FGSVGGGILSSFLIGRGLDPIKARLVSMLLFACCIIGVIMAAGASNLWMAVFAISLAIGA HQAWTANIWSLVMDYTPKHMMSTVFGFGGMCAAIGGMFMTQLVGHILTVTNNNYTVLFTL IPAMYFTALIWLYFMAPRKVPTLEN
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server